Big data will open Pandora’s box
content-image
Science
00

2036

What will the future of healthcare and pharmaceutical research look like? What will be the focus of the industry in 15 years’ time? How will society approach healthcare? Back in 2016, live asked Swiss futurist Georges T. Roos to give us his predictions for the year 2036. Some of his visions have already come true, some seem as distant as ever.

by Georges T. Roos*

scroll-down
Home
en
de
zh
jp
Share
Share icon
content-image
Enter fullscreen

Sunset over a Google data center in Belgium.

Published on 02/03/2021

First, a disclaimer: The future is uncertain – more uncertain than it has ever been. Making prognoses is a risky venture. Between now and 2036, many things will happen that we never saw coming. Nevertheless, I daresay that health is one of the aspects of human life that will have fundamentally changed by then. Alongside the next digital revolution and profound demographic changes, healthcare has the potential to disrupt our future. By this I mean that it is an aspect of life that would be unrecognizable to us if we fast-forwarded to the year 2036.

Transhumanists – heralds of a new era of human health

Ray Kurzweil, Google’s current director of engineering, is a tech visionary. In his much-quoted book The Age of Spiritual Machines, Kurzweil describes a world in which intelligent machines give rise to even more intelligent machines, a moment which Kurzweil defines as singularity. Less well-known is the fact that Kurzweil ingests 150 to 200 dietary supplement tablets every day, hoping that by doing so he will be able to carry on living until technology allows us to digitize human intelligence. Kurzweil advocates transhumanism. Transhumanists want to take evolution into their own hands, as it were, with the aim of enhancing their human capacities through implants, pharmacology, genetic engineering and brain stimulation. Fatal diseases will be a thing of the past. Even if death can’t be overcome, transhumanists believe that human consciousness should live on in the digital world.

Given their eccentric views, it is easy to dismiss transhumanists as crazy. On the other hand, it is now possible to replace nearly half of the human body with robotic parts. There is even such a thing as artificial blood, as featured in the Smithsonian Channel documentary The Incredible Bionic Man, which showed prosthetic parts being combined to create a functioning artificial body. It is only a matter of time before some man-made body parts become more effective than their natural equivalents. Future generations will then have to wrestle with conundrums such as, “Should I replace a natural organ that functions perfectly well with an artificial organ that functions even better?”, and “Should I do so in a pre-emptive manner or wait until the original organ actually begins to malfunction?” It is a scenario that may still seem absurd to some, but I would suggest that Kurzweil and his ilk are articulating the early signs of a paradigm shift with regard to health.

Enhancing human performance

The way in which society views health is changing constantly. In the past, being healthy simply meant not being ill. This healthcare paradigm could be described as “repair medicine,” since all efforts were directed towards rectifying ailments when they arose. Once the disease was treated, life would move on and the issue of health would disappear. This paradigm has become outdated over the past few decades. Nowadays it is no longer enough to be free of illness. Increasingly the focus is on how we can actively improve our health. Those who veer from the health-conscious route of practicing sport, eating healthily or having regular preventive check-ups are under pressure to justify themselves. The same applies to the corporate world: Health at work is no longer simply a matter of increasing workplace safety. Today, companies are also expected to proactively promote employee health. Many industries besides the pharmaceutical sector are catering to the emergence of a new “health culture.” The food business and, of course, the fitness and spa industry are also embracing and strengthening this trend.

So much for the present. As far as the next 15 years are concerned, the emphasis will shift towards enhancing human performance. Numerous early clues suggest that health will revolve around the issue of how we can improve our physical, psychological and intellectual capabilities. The increasing use of mobile apps to measure our performance is one such precursor of this trend. Wristbands, T-shirts, “smart” patches, subcutaneous microchips and other gadgets equipped with sensors now count the number of steps we walk and measure our stress, blood pressure and blood sugar levels. Algorithms analyze the data via smartphone and translate them into real-time information about the user’s current state of health. Athletes and high-risk patients – as well as die-hard technology geeks – are among the early adaptors. In the near future, such apps will also be used by healthy people who wish to improve their performance.

In my view another early signal is that young people are prepared to enhance their performance by consuming energy drinks, drugs or medication. Society frowns upon athletes who dope, but sexual and psychological doping now enjoy widespread acceptance. Brain doping is becoming ever more popular: According to a study by the universities of Zurich and Basel, one in seven students has ingested neuro-enhancers in order to perform better in exams. There is not enough space in this article to list every single harbinger to support my hypothesis, but one final point worth mentioning is that Assisted Reproduction Treatments (ART) doubled in Switzerland between 2002 and 2014. While mostly couples with infertility problems use ART, there is also increasing demand for this technology to bypass the biological clock. Children by all means, but not at the expense of our careers!

content-image
Enter fullscreen

Diagnosis of an overheated processor in a Google data center in Oregon, USA.

Big data will open Pan­do­ra’s box

This paradigm shift reflects a value change with respect to health and nature. The value shift is largely attributable to the phenomenal advances that have been made in the realm of life sciences such as biology, bioinformatics and genetic engineering. Disruptive information technologies are also fanning this development. One key aspect is the convergence of different academic disciplines, lifting medical science to a new level. Take the human genome, for example, which these days costs barely 1000 US dollars to sequence. Today, the sequencing results still resemble a dictionary without definitions. The function of many of the 25 000 human genes is unknown. But what will be the upshot if we can compare the genomes of millions of people, check them against every person’s history of illness, feed lifestyle-related data into the equation and then use new technologies to extract intelligent hypotheses from all the data? Once this is possible – and it will be sooner rather than later – we will see a quantum leap in the world of healthcare. The technology needed to process such huge amounts of data is looming on the horizon. Some call it “big data,” others refer to “cognitive computing.” In my view, it is only now that we can begin to talk about Artificial Intelligence, or AI. Watson, the name of an AI platform that IBM developed specifically for the purpose of answering questions on the television quiz show Jeopardy!, is the best example of what I mean. Watson took the show by storm in 2011, beating its human opponents. What was fascinating about Watson was its ability to understand natural language, form and test its own hypotheses, and learn on the basis of the evidence it gathered. Since the game show, IBM has continually evolved Watson, which today is being used to help in the diagnosis and treatment of skin cancer, for example. The system should also help in dramatically accelerating the expensive drug development process.

Disruptive advances in the healthcare sector

In short, data are the key drivers that will disrupt the healthcare sector. Genomics generate huge amounts of data, as do mobile apps that measure our performance. Provided they are collected and analyzed in an intelligent manner, such data will shed new light on the interplay between lifestyle habits, illnesses and changes in human capacity. We will thus have a powerful tool to measure the effectiveness of medicines. Heralding the advent of personalized medicine, drugs will be tailored to specific genotypes. AI might also help us to detect previously unknown substances.

The central role of data and data processing will challenge the pharmaceutical sector in a manner already seen in other industries. Facebook is the world’s largest media channel but creates no content itself. AirBnB is the world’s biggest accommodation provider but does not own any real estate. Uber is the world’s biggest taxi company but has no vehicles or drivers. Alibaba is the world’s most valuable retailer but has no shops. Something similar could also happen to the pharmaceutical industry by 2036 – with IT companies acting as vital partners. The IT sector may have no patients, hospitals or research laboratories of its own, but it holds the key to the gold of tomorrow: data.

*Georges T. Roos is an independent futurist. Prior to founding the future studies institute ROOS Trends & Futures in 2000, he was a member of the executive board of the Gottlieb Duttweiler Institute. Roos specializes in the megatrends of social change, disruptive scenarios and the early identification of future trends. This article was originally published in the print edition of live in March 2016.

icon

Home
en
de
zh
jp
Share
Share icon